These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12187845)

  • 1. Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.
    Matsuura E; Kobayashi K; Kasahara J; Yasuda T; Makino H; Koike T; Shoenfeld Y
    Int Rev Immunol; 2002; 21(1):51-66. PubMed ID: 12187845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody-mediated atherosclerosis.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y
    Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.
    Kobayashi K; Matsuura E; Liu Q; Furukawa J; Kaihara K; Inagaki J; Atsumi T; Sakairi N; Yasuda T; Voelker DR; Koike T
    J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
    Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
    Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
    Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.
    Liu Q; Kobayashi K; Furukawa J; Inagaki J; Sakairi N; Iwado A; Yasuda T; Koike T; Voelker DR; Matsuura E
    J Lipid Res; 2002 Sep; 43(9):1486-95. PubMed ID: 12235181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
    Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
    J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
    Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages.
    Hasunuma Y; Matsuura E; Makita Z; Katahira T; Nishi S; Koike T
    Clin Exp Immunol; 1997 Mar; 107(3):569-73. PubMed ID: 9067534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
    Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
    J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
    Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
    Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
    J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and atherosclerosis.
    Matsuura E; Kobayashi K; Yasuda T; Koike T
    Lupus; 1998; 7 Suppl 2():S135-9. PubMed ID: 9814691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
    Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR
    QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.